Page last updated: 2024-10-30

4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide and Cryptogenic Fibrosing Alveolitis

4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

4-(dimethylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)benzamide: structure in first source
4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide : A benzamide resulting from the formal condensation of the carboxy group of 4-(dimethylamino)benzoic acid with the amino group of 7-amino-N-hydroxyheptanamide. It is a potent inhibitor of histone deacetylases and induces cell cycle arrest and apoptosis in several human cancer cell lines.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lu, W1
Yao, X1
Ouyang, P1
Dong, N1
Wu, D1
Jiang, X1
Wu, Z1
Zhang, C1
Xu, Z1
Tang, Y1
Zou, S1
Liu, M1
Li, J1
Zeng, M1
Lin, P1
Cheng, F1
Huang, J1

Other Studies

1 other study available for 4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide and Cryptogenic Fibrosing Alveolitis

ArticleYear
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
    Journal of medicinal chemistry, 2017, 03-09, Volume: 60, Issue:5

    Topics: Acute Lung Injury; Animals; Epoxide Hydrolases; Female; Histone Deacetylase Inhibitors; Idiopathic P

2017